https://www.selleckchem.com/pr....oducts/pf-05251749.h
rvention and mortality p less then 0.001(OR9.05; CI 95%4.52-18.11), and less then 0.001 (4.00; 2.46-6.49), respectively. CONCLUSIONS Our experience seems to suggest that EVAR could safely and effectively performed in an unselected patients' population, with encouraging results up to ten-year follow-up. BACKGROUND Primary mycotic aneurysm of the aorta (MAA) is a rare and potentially life threatening disease. Endovascular aneurysm repair (EVAR) of MAAs involving the paravisceral has been rarely reported. The purpose of this study is t